Clinical trial
STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable…
NCT00263237 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00263237 |
|---|---|
| Title | STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency |
| Official title | A Pilot Study of Safety and Efficacy of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Common Variable Immunodeficiency |
| Intervention type | Drug |
| Interventions | STA-5326 |
| Enrollment | 10 |
| Start date | Dec 2, 2005 |
| Completion | Jul 23, 2008 |
| First posted | Dec 7, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: